Harrow Inc $HROW

Recent News (4)

• Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target Yahoo Finance · 20 Aug 2026 Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target
• Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine? Yahoo Finance · 13 Aug 2026 Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
• Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease GlobeNewswire · 06 Aug 2026 NASHVILLE, Tenn., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has entered into a …
• Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting GlobeNewswire · 20 Jul 2026 NASHVILLE, Tenn., July 20, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the presentation of three s…